MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

GenMark Diagnostics Company Profile (NASDAQ:GNMK)

Consensus Ratings for GenMark Diagnostics (NASDAQ:GNMK) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.50 (61.65% upside)

Analysts' Ratings History for GenMark Diagnostics (NASDAQ:GNMK)
Show:
DateFirmActionRatingPrice TargetActions
5/23/2015Canaccord GenuityReiterated RatingBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015BTIG ResearchReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Canaccord GenuityLower Price TargetBuy$16.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2015BTIG ResearchReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2015Canaccord GenuityLower Price TargetIn-Line -> Buy$17.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2015Needham & Company LLCSet Price TargetBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Needham & Company LLCSet Price TargetBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015BTIG ResearchReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Canaccord GenuitySet Price TargetBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2014BTIG ResearchUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2014Raymond JamesReiterated RatingOutperform$11.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Raymond JamesReiterated RatingOutperform$14.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingOverweight$17.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Cowen and CompanyReiterated RatingOutperform$16.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/24/2014Canaccord GenuityBoost Price Target$14.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2013Needham & Company LLCInitiated CoverageBuy -> Buy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2013Raymond JamesLower Price TargetOutperform$15.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2013Piper JaffrayReiterated RatingOverweight$9.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2013Raymond JamesBoost Price Target$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2013Raymond JamesLower Price Target$13.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2013Canaccord GenuityLower Price TargetBuy$18.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/6/2013 forward)